Secondary Hemophagocytic Lymphocytosis in Inflammatory Bowel Disease
- PMID: 40700100
- PMCID: PMC12286110
- DOI: 10.3390/hematolrep17040033
Secondary Hemophagocytic Lymphocytosis in Inflammatory Bowel Disease
Abstract
Background and Clinical Significance: Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening condition that can go underdiagnosed due to overlapping features with severe infections. While the use of thiopurine in inflammatory bowel disease (IBD) has been associated with HLH, the majority of these patients will have a concurrent Epstein-Barr virus (EBV) infection. Case Presentation: This report presents a case of HLH in a patient previously treated with aza-thioprine for IBD without concurrent viral infection.
Keywords: hemophagocytic lymphocytosis; inflammatory bowel disease; pancytopenia.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
A case of acute myeloid leukemia with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis successfully treated by cord blood transplantation.J Infect Chemother. 2025 Aug;31(8):102767. doi: 10.1016/j.jiac.2025.102767. Epub 2025 Jul 5. J Infect Chemother. 2025. PMID: 40618848
-
Fatal HLH in patients with X-linked lymphoproliferative disease 1 due to a novel variant in SH2D1A: case report.Front Immunol. 2025 May 19;16:1602107. doi: 10.3389/fimmu.2025.1602107. eCollection 2025. Front Immunol. 2025. PMID: 40458416 Free PMC article.
-
Hemophagocytic lymphohistiocytosis in a patient with Epstein-Barr virus-positive diffuse large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy.Immunotherapy. 2024;16(18-19):1105-1111. doi: 10.1080/1750743X.2024.2409622. Epub 2024 Oct 17. Immunotherapy. 2024. PMID: 39417342
-
Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a systematic review and meta analysis.Eur Rev Med Pharmacol Sci. 2012 May;16(5):672-8. Eur Rev Med Pharmacol Sci. 2012. PMID: 22774410
-
Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.Cochrane Database Syst Rev. 2014 Oct 23;2014(10):CD007744. doi: 10.1002/14651858.CD007744.pub2. Cochrane Database Syst Rev. 2014. PMID: 25340915 Free PMC article.
References
-
- Abdelhay A., Mahmoud A.A., Al Ali O., Hashem A., Orakzai A., Jamshed S. Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006–2019: A national, retrospective cohort study. EClinicalMedicine. 2023;62:102143. doi: 10.1016/j.eclinm.2023.102143. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources